Massachusetts Financial Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $389M | Sell |
|
|||||
|
2022
Q2 | $512M | Buy |
|
|||||
|
2022
Q1 | $532M | Sell |
|
|||||
|
2021
Q4 | $591M | Buy |
|
|||||
|
2021
Q3 | $513M | Buy |
|
|||||
|
2021
Q2 | $385M | Buy |
|
|||||
|
2021
Q1 | $291M | Sell |
|
|||||
|
2020
Q4 | $319M | Buy |
|
|||||
|
2020
Q3 | $270M | Buy |
|
|||||
|
2020
Q2 | $225M | Buy |
|
|||||
|
2020
Q1 | $194M | Sell |
|
|||||
|
2019
Q4 | $375M | Buy |
|
|||||
|
2019
Q3 | $330M | Buy |
|
|||||
|
2019
Q2 | $271M | Buy |
|
|||||
|
2019
Q1 | $270M | Buy |
|
|||||
|
2018
Q4 | $216M | Sell |
|
|||||
|
2018
Q3 | $370M | Sell |
|
|||||
|
2018
Q2 | $313M | Buy |
|
|||||
|
2018
Q1 | $285M | Buy |
|
|||||
|
2017
Q4 | $229M | Buy |
|
|||||
|
2017
Q3 | $218M | Buy |
|
|||||
|
2017
Q2 | $233M | Buy |
|
|||||
|
2017
Q1 | $161M | Buy |
|
|||||
|
2016
Q4 | $147M | Buy |
|
|||||
|
2016
Q3 | $106M | Buy |
|
|||||
|
2016
Q2 | $22.4M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $1.03M | Sell |
|
|||||
|
2015
Q3 | $20.7M | Sell |
|
|||||
|
2015
Q2 | $23.2M | Buy |
|
|||||
|
2015
Q1 | $22.6M | Buy |
|
|||||
|
2014
Q4 | $655K | Buy |
|
|||||
|
2014
Q3 | $473K | Buy |
|